clinical practice guidelines _ blood product prescription

Upload: fadhita-maisa-asri

Post on 05-Jul-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/16/2019 Clinical Practice Guidelines _ Blood Product Prescription

    1/5

    23/05/2016 Clinical Practice Guidelines : Blood Product Prescription

    http://www.rch.org.au/clinicalguide/guideline_index/Blood_Product_Prescription/ 1/5

    Blood Product Prescription

    Ind ications for transf usions:Red Blood CellsPlateletsFresh Frozen PlasmaCryoprecipitate

    Pre-transfusion assessmentTable: Transfusion Volumes and Rates

    Management of transfusionComplications

    After transfusionWhen patients or families refuse a blood product transfusi on RCH PolicyOther resources

    Please read in conjunction with: Massive transfusion and critical bleeding procedure

    Blood transfusion procedure

    Backgrou ndBlood and blood product transfusions may be required for acute blood loss, or for failure of productionsuch as bone marrow suppression.Blood pr oduct therapy sho uld only be given when the expected benefits to the patient are likely tooutweigh the potentia l hazards.

    All blood transfusion activ ity within the RCH must occur in compliance with the relevant policies (needslink) and hospital clinical guidelines (link needed).

    Indications for TransfusionRed blood cellsPlateletsFresh Frozen PlasmaCryoprecipitate

    Indications for Red Blood Cells

    Hb

  • 8/16/2019 Clinical Practice Guidelines _ Blood Product Prescription

    2/5

    23/05/2016 Clinical Practice Guidelines : Blood Product Prescription

    http://www.rch.org.au/clinicalguide/guideline_index/Blood_Product_Prescription/ 2/5

    transportHb

  • 8/16/2019 Clinical Practice Guidelines _ Blood Product Prescription

    3/5

    23/05/2016 Clinical Practice Guidelines : Blood Product Prescription

    http://www.rch.org.au/clinicalguide/guideline_index/Blood_Product_Prescription/ 3/5

    All immuno-compromised patients, including all oncology patients, cardiac neonates andall patients in ICU, to prevent graft-versus host disease.

    CMV negative products:Leucocyte depleted blood products, are considered an acceptable alternative to CMVseronegative products at RCH

    5. Calculate & prescribe the transfusion volume with consideration to pack sizesUnstable patient - See Massive transfusion and critical bleeding procedureStable patient (see Table 2 below)

    6. Prescribe the blood product and rate of administration on the fluid order chart (see Table 2 below) All transfusions must be completed within 4 hours of spiking a pack.

    Table 2: Transfusion volumes and rates

    Blood product Formula for calculatingtransfusion

    volume

    Pack sizes Rate

    RedBlood Cells

    Packed cells(mls)= wt (kg) x Hbriserequired(g/L) x0.4

    (eg.10kg

    child requiringHb to rise from60 to 110g/L: 10x 50 x0.4=200ml)

    250-300ml/pack;

    50 -60ml/Pedipack

    Transfusion will be started at a slower rate (eg.Half the rate) for the first 15minutes. If noadverse effects occur, increase the transfusionto a 2-4hourly rate depending on the patient'scondition and fluid balance

    Platelets 5 - 20 ml/kg

    (5 - 10 ml/kg willraise plateletcount by 50 -100x 10 /L)

    Neonatal/paediatric

  • 8/16/2019 Clinical Practice Guidelines _ Blood Product Prescription

    4/5

    23/05/2016 Clinical Practice Guidelines : Blood Product Prescription

    http://www.rch.org.au/clinicalguide/guideline_index/Blood_Product_Prescription/ 4/5

    Paediatric >40kg or adult:

    Apheresis(singledonor)>200mlor split

    into 2 x >100mlpacksPooledfrom 4-5donors ->160ml

    FFP 10 - 20 ml/Kg 300ml/pack

    50ml/pack (for neonatal use)

    Start at no more than 5ml/min.

    Cryoprecipitate 5-10 ml/kg 30-40 ml/pack Start at no more than 5ml/min.

    Management of Transfusion Administer as per Blood transfusion procedure

    The key steps include:

    1. A formal checking process prior to commencement of transfusion2. The use of correct equipment (filters, pump, consideration of blood warmer)3. Correct transfusion documentation including patient observations, start and finish times

    Complications during transfusion:The most common immediate adverse reactions to transfusion are fever, chills and urticaria.The most potentially significant reactions include acute haemolytic transfusion reactions, bacterialcontamination of blood products and transfusion related acute lung injury.During the early stages of a reaction it may be difficult to ascertain the cause.

    All suspected transfusion reactions must be reported to the issuing blood bank immediately. The on-call haematologist will contact the clinical area to provide advice regarding investigation and ongoingtransfusion support.

    After transfusion:Document the effect of transfusion on the patient's condition including Hb if repeated.

    Other resourcesRCH Blood transfusion website

    http://www.rch.org.au/bloodtrans/about_blood_productshttp://www.rch.org.au/policy/policies/Blood_Product_Transfusion/

  • 8/16/2019 Clinical Practice Guidelines _ Blood Product Prescription

    5/5

    23/05/2016 Clinical Practice Guidelines : Blood Product Prescription

    http://www.rch.org.au/clinicalguide/guideline_index/Blood_Product_Prescription/ 5/5

    Content authorised by: Webmaster. Enquiries: Webmaster.

    mailto:[email protected]:[email protected]